Mounjaro®
Starting from £179.99/mo
Start journey Learn moreLosing 5 stone (31.75 kg) on Mounjaro is within the range suggested by clinical trial data, though the timeline varies considerably between individuals. In SURMOUNT-1, participants taking tirzepatide 15mg lost an average of around 20–21% of body weight over 72 weeks — for someone starting at roughly 22–23 stone, that arithmetic lands close to 5 stone. Real-world timelines depend on your starting weight, the dose you reach, how your body responds, and the lifestyle changes you make alongside treatment. Mounjaro (tirzepatide) is a prescription-only medicine; a GPhC-registered prescriber assesses whether it is clinically appropriate before treatment begins.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
The clearest reference point for 5-stone expectations comes from SURMOUNT-1, published in the New England Journal of Medicine. The trial followed 2,539 adults with obesity over 72 weeks. At the highest dose studied (15mg), average weight reduction reached roughly 20–21%. To put that in stone terms: a person starting at 24 stone and achieving 20% loss would shed just under 5 stone. Someone starting at 20 stone would need closer to 25% (above the average) to cross the same threshold.
That distinction matters. The trial result is an average across a large group. Some participants lost considerably more, others less. Your starting weight sets the baseline from which any percentage is calculated, so two people on identical doses can end up with very different stone totals even if their percentage loss is similar.
72 weeks is around 17 months. Not all of that loss arrives evenly: the rate tends to be faster in the first few months once an effective dose is established, then gradually slows as the body adapts. Knowing this can help you interpret your own progress without losing confidence when the scales move more slowly in month eight than they did in month three.
Mounjaro treatment starts at 2.5mg, a dose whose job is to let your system adjust, not to drive significant weight loss. The NHS medicines page for tirzepatide describes the escalation pathway: doses increase, typically every four weeks, through 5mg, 7.5mg, 10mg, 12.5mg and 15mg, guided by the prescriber at each step. Reaching the top of that ladder takes roughly five months at minimum, and many people stabilise at an intermediate dose that suits them better.
This means your first few months on Mounjaro may produce more modest results than the trial's headline figures suggest. The landmark losses tend to accumulate once you are at a stable, effective dose. For people targeting 5 stone, patience across the titration phase is genuinely important rather than a platitude. Comparing your week-eight progress to someone else's month-twelve result is not a fair test.
One practical habit worth building: weigh yourself at the same time of day, on the same day each week, wearing similar clothing. A single weekly data point taken consistently is more informative than daily fluctuations and gives you a cleaner picture of your actual trajectory. It takes under a minute and removes a lot of unnecessary noise.
Trial conditions are controlled; real life is not. Several factors influence how quickly (or slowly) 5 stone comes off in practice.
Starting weight is the most obvious lever: a higher starting weight means a given percentage reduction produces a larger absolute number on the scales. Metabolic factors, age, activity level and how closely a person maintains a reduced-calorie diet alongside treatment all play a role. The NICE appraisal of tirzepatide (TA1026) recommends reviewing progress at six months: if weight loss is less than 5% of starting weight by that point, the prescriber will discuss whether continuing makes sense. That review is not a penalty, it is a clinical check-in that protects you from prolonged treatment without meaningful benefit.
Digestion also changes on tirzepatide. Gastric emptying slows, which contributes to the feeling of fullness that reduces appetite. For some people, this leads to very consistent appetite suppression from early in treatment; for others the effect builds gradually. If you want to understand how those digestive changes actually work, the page on how digestion changes on Mounjaro covers the mechanism in more detail.
People sometimes ask whether results slow after the first stone or two. Broadly, yes. Weight loss in trials followed a pattern common to most effective interventions: steeper early, then a plateau. The plateau does not mean the medicine has stopped working, it often reflects the body settling at a lower set-point. For someone targeting 5 stone, reaching 3 stone and stalling is not unusual, and if you want a detailed look at what the evidence suggests around that point, the guide on how long it typically takes to lose 3 stone on Mounjaro is worth reading before adjusting your dietary approach or activity with your prescriber.
Five stone is a substantial goal. For many people it is achievable on Mounjaro given enough time and the right dose, but it is not guaranteed and it is not fast. The trial ran for 72 weeks for a reason. Anyone offering you a shorter, certain timeline is not working from the evidence.
If you are earlier in your journey and wondering how the milestones typically stack up, the guides on losing a stone on Mounjaro and losing 2 stone break down the shorter-range picture in the same evidence-based way. For those whose targets sit beyond 5 stone, the guide on how long it takes to lose 4 stone on Mounjaro is a useful stepping-stone reference, and the 6-stone page looks at what the data suggests at greater starting weights.
If you develop severe, persistent stomach pain (particularly pain that radiates toward your back) seek medical help promptly. Acute pancreatitis is a known, infrequent side effect of GLP-1 medicines; the MHRA highlighted this in a January 2026 Drug Safety Update. It is rare, but it is the kind of symptom that should not be waited out at home.
Treatment decisions, dose adjustments and realistic timeline discussions all belong with a prescriber who knows your full medical picture. If you would like that conversation with a clinical team, you can start your free consultation with nume, a GPhC-registered Independent Prescriber reviews every submission the same day.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.